Joshua Reineke

Joshua Reineke

Auto-generated profile, based on publicly available information

Joshua Reineke

Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions, South Dakota State University, Brookings, SD, United States

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2010 in ACS Nano
Verified
Journal Article
Closed access
MLMingguang Li
Mingguang Li
KAKhuloud T. Al-Jamal
Khuloud T. Al-Jamal
KKKostas Kostarelos
Kostas Kostarelos
JRJoshua Reineke
Joshua Reineke

21 August 2018 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
MDMikhail Durymanov
Mikhail Durymanov
JRJoshua Reineke
Joshua Reineke
Delivery of genes, including plasmid DNAs, short interfering RNAs (siRNAs), and messenger RNAs (mRNAs), using artificial non-viral nanotherapeutics is a promising approach in cancer gene therapy. However, multiple physiological barriers upon systemic administration remain a key challenge in clinical translation of anti-cancer gene therapeutics. Besides extracellular barriers including sequestration of gene delivery nanoparticles from the bloodstream by resident organ-specific macrophages, and their poor extravasation and tissue penetration in tumors, overcoming intracellular barriers is also necessary for successful delivery of nucleic acids. Whereas for RNA delivery the endosomal barrier holds a key importance, transfer of DNA cargo additionally requires translocation into the nucleus. Better understanding of crossing membrane barriers by nucleic acid nanoformulations is essential to the improvement of current non-viral carriers. This review aims to summarize relevant literature on intracellular trafficking of non-viral nanoparticles and determine key factors toward surmounting intracellular barriers. Moreover, recent data allowed us to propose new interpretations of current hypotheses of endosomal escape mechanisms of nucleic acid nanoformulations.

2 April 2013 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
AMAbdul Khader Mohammad
Abdul Khader Mohammad
JRJoshua J. Reineke
Joshua J. Reineke

6 August 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JRJoshua J. Reineke
Joshua J. Reineke
DCDaniel Y. Cho
Daniel Y. Cho
YDYu-Ting Dingle
Yu-Ting Dingle
AMA. Peter Morello
A. Peter Morello
JJJules Jacob
Jules Jacob
EMEdith Mathiowitz
Edith Mathiowitz
Polymeric microspheres (MSs) have received attention for their potential to improve the delivery of drugs with poor oral bioavailability. Although MSs can be absorbed into the absorptive epithelium of the small intestine, little is known about the physiologic mechanisms that are responsible for their cellular trafficking. In these experiments, nonbiodegradable polystyrene MSs (diameter range: 500 nm to 5 µm) were delivered locally to the jejunum or ileum or by oral administration to young male rats. Following administration, MSs were taken up rapidly (≤5 min) by the small intestine and were detected by transmission electron microscopy and confocal laser scanning microscopy. Gel permeation chromatography confirmed that polymer was present in all tissue samples, including the brain. These results confirm that MSs (diameter range: 500 nm to 5 µm) were absorbed by the small intestine and distributed throughout the rat. After delivering MSs to the jejunum or ileum, high concentrations of polystyrene were detected in the liver, kidneys, and lungs. The pharmacologic inhibitors chlorpromazine, phorbol 12-myristate 13-acetate, and cytochalasin D caused a reduction in the total number of MSs absorbed in the jejunum and ileum, demonstrating that nonphagocytic processes (including endocytosis) direct the uptake of MSs in the small intestine. These results challenge the convention that phagocytic cells such as the microfold cells solely facilitate MS absorption in the small intestine.

1 September 2017 in Journal of Controlled Release
Verified
Journal Article
Closed access
MDMikhail Durymanov
Mikhail Durymanov
TKTatiana Kamaletdinova
Tatiana Kamaletdinova
SLSarah E. Lehmann
Sarah E. Lehmann
JRJoshua Reineke
Joshua Reineke

2 June 2016 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
QZQian Zhong
Qian Zhong
EBElizabeth R. Bielski
Elizabeth R. Bielski
LRLeonan S. Rodrigues
Leonan S. Rodrigues
MBMatthew R. Brown
Matthew R. Brown
JRJoshua J. Reineke
Joshua J. Reineke
SRSandro R.P. da Rocha
Sandro R.P. da Rocha